Wednesday, July 8, 2026
🇺🇸 FDA

biotech · Bile acid diarrhoea · Transthyretin cardiac amyloidosis · GLUE

Monte Rosa Therapeutics

Monte Rosa Therapeutics patent portfolio — 72 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
Boston, USA HQ
213 Employees
Public company Type
GLUE · NYSE Ticker
Company details
Status
Public
HQ
Boston, USA
Employees
213
Programs
7
Drugs
14
Patents
72
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

Monte Rosa Therapeutics patents

72 pharmaceutical patents indexed for Monte Rosa Therapeutics. 5 expire within 24 months.

Monte Rosa Therapeutics has 72 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 5 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

72 patents

Patent portfolio

Page 1 of 2

  1. US 12391663

    Isoindolinone compounds

    Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12378199

    Rigidified pentadentate chelating agents useful for the [Al18F]2+ labelling of biomolecules

    Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12280029

    Methods of treatment of inflammation related conditions using pluripotent anti-inflammatory and metabolic modulators

    Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12263143

    Ionic channel modulation as a method for treating tumors through inflammasome activation

    Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12257247

    Targeted degradation of VAV1

    Expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12214218

    Perfusion modulated tumor dose sculpting with single dose radiotherapy

    Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12070628

    Low energy immune priming for treating cancer and metastasis

    Expires Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12011619

    Low intensity focused ultrasound for treating cancer and metastasis

    Expires Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11912682

    Isoindolinone compounds

    Expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11787778

    Bi-functional compounds and methods for targeted ubiquitination of androgen receptor

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11547759

    Bi-functional compounds and methods for targeted ubiquitination of androgen receptor

    Expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11413255

    Multifunctional cytoprotectant for treatment of pathogenic processes mediated by oxidative stress and toxic electrophiles

    Expires Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11400066

    Methods of treatment of inflammation related conditions using pluripotent anti-inflammatory and metabolic modulators

    Expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11344631

    Promoter for cell-specific gene expression and uses thereof

    Expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11279922

    Delivery of therapeutic agents by a collagen binding protein

    Expires Mon Mar 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11246858

    Immunoresponsive methods of treating tumors

    Expires Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11230587

    Ligands of B7H receptor in the treatment of osteopenia and osteoporosis

    Expires Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11098025

    Bi-functional compounds and methods for targeted ubiquitination of androgen receptor

    Expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11001820

    Delivery of therapeutic agents by a collagen binding protein

    Expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10974077

    Low intensity focused ultrasound for treating cancer and metastasis

    Expires Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 10932484

    Inhibitory activity of acetogenins against Listeria monocytogenes

    Expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 10906864

    Nitroalkene non steroidal anti-inflammatory drugs (NA-NSAIDS) and methods of treating inflammation related conditions

    Expires Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 10874748

    Intervention for tendinopathy

    Expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 10772846

    Methods and compositions for treating and preventing arthritis

    Expires Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 10582707

    Antimicrobial antibacterial and spore germination inhibiting activity from an avocado extract enriched in bioactive compounds

    Expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 10575521

    Antimicrobial, antibacterial and spore germination inhibiting activity from an avocado extract enriched in bioactive compounds

    Expires Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 10537537

    Methods of treatment of inflammation related conditions using pluripotent anti-inflammatory and metabolic modulators

    Expires Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 10519138

    Modulators of SOCE, compositions, and uses thereof

    Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 10493057

    Acetogenin molecules having antiplatelet and/or antithrombic activities, and methods and compositions thereof

    Expires Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 10428008

    Nitroalkene non steroidal anti-inflammatory drugs (NA-NSAIDs) and methods of treating inflammation related conditions

    Expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 10368569

    Natural sweetener

    Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 10213488

    Delivery of therapeutic agents by a collagen binding protein

    Expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 10111925

    Formulations comprising plant extracts

    Expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 10111912

    Herbal formulations

    Expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 10104882

    Methods and compositions for preventing and treating electrophile-mediated toxicities

    Expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 10034919

    Targeted human-interferon fusion proteins

    Expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9913869

    Formulations comprising herbal extracts

    Expires Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9585928

    Agave syrup extract having anticancer activity

    Expires Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9579273

    Delivery of therapeutic agents by a collagen binding protein

    Expires Mon Feb 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9556438

    Gene vector

    Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9526765

    Delivery of therapeutic agents by a collagen binding protein

    Expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9445870

    Methods and devices for crosslinking of corneal collagen and for treatment of disorders of the eye

    Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9314486

    Preparative regimen for engraftment, growth and differentiation of non-hematopoeitic cells in vivo after transplantation

    Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8992930

    Extracellular IFI16 as therapeutic agents

    Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8841288

    Quinolin-4 (1H)-one derivatives as inhibitors of phosphatidylinositol 3-kinases

    Expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8835510

    Methods and compositions for treating conditions mediated by oxidative stress or electrophilic environmental toxins

    Expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8765717

    Meloxicam and glucosamine formulation and uses thereof

    Expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8574653

    Intermittent flow extrusion process and food product

    Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Monte Rosa Therapeutics have?

72 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Monte Rosa Therapeutics patents expire?

5 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.